Neurosteroid modulation of GABAA receptors

Progress in Neurobiology

Volumn 71, Issue 1, 2003, Pages 67-80

  Lambert, Jeremy J ^a   Belelli, Delia ^a   Peden, Dianne R ^a   Vardy, Audrey W ^a   Peters, John A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA 17 [BIS(1 METHYLETHYL)AMINOCARBONYL]ANDROSTANE 3,5 DIENE 3 CARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A ALPHA RECEPTOR; 4 AMINOBUTYRIC ACID A BETA RECEPTOR; 4 AMINOBUTYRIC ACID A DELTA RECEPTOR; 4 AMINOBUTYRIC ACID A EPSILON RECEPTOR; 4 AMINOBUTYRIC ACID A GAMMA RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ALFAXALONE; ANABOLIC AGENT; BENZODIAZEPINE DERIVATIVE; BICUCULLINE; CHLORIDE CHANNEL; CORTICOSTERONE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DIAZEPAM; ENZYME INHIBITOR; ETOMIDATE; FLUNITRAZEPAM; LORECLEZOLE; METHYLTESTOSTERONE; MUSCIMOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NANDROLONE; NEUROSTEROID; PREGNANE DERIVATIVE; PROTEIN KINASE C INHIBITOR; RECEPTOR SUBUNIT; SKF 105111; STANOZOLOL; TETRAHYDROPROGESTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTICONVULSANT ACTIVITY; BRAIN REGION; CHANNEL GATING; DRUG RECEPTOR BINDING; HORMONAL REGULATION; HORMONE ACTION; NERVE ENDING; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PURKINJE CELL; RECEPTOR SENSITIVITY; REVIEW; SEDATION; STEROID METABOLISM; STEROIDOGENESIS; SYNAPTIC INHIBITION; TRANQUILIZING ACTIVITY;

EID: 0242552669     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2003.09.001     Document Type: Review

References (108)

1. A receptors in hippocampal neurons. Mol. Pharmacol. 59:2001;814-824.
2. Barker J.L., Harrison N.L., Lange G.D., Owen D.G. Potentiation of γ-aminobutyric-acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurons. J. Physiol. (Lond.). 386:1987;485-501.
3. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50:1998;291-313.
4. A receptor-mediated inhibitor neurotransmission in the hippocampus: evidence for endogenous neurosteroids? J. Neurosci., in press.
5. Belelli D., Lambert J.J., Peters J.A., Wafford K., Whiting P.J. The interaction of the general anesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11031-11036.
6. Belelli D., Pistis I., Peters J.A., Lambert J.J. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol. Sci. 20:1999;496-502.
7. A receptors. Neuropharmacology. 43:2002;651-661.
8. A receptor in general anaesthesia. Neuropharmacology. 45:2003;57-71.
9. A-receptor plasticity during long-term exposure to and withdrawal from progesterone. Int. Rev. Neurobiol. 46:2001;207-241.
10. A receptors. J. Physiol. (Lond.). 497:1996;753-759.
11. Brickley S.G., Revilla V., Cull-Candy S.G., Wisden W., Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature. 409:2001;88-92.
12. A receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J. Neurochem. 77:2001;1266-1278.
13. Brown, R.C., Papadopoulous, V., 2001. Role of the peripheral-type benzodiazepine receptor in adrenal brain steroidogenesis. In: Biggio, G., Purdy, R.H. (Eds.), Neurosteroids and Brain Function; Int. Rev. Neurobiol. 46, 117-143.
14. A receptors. Br. J. Pharmacol. 136:2002;965-974.
15. A receptor subunit expression. Neuron. 19:1997;1103-1114.
16. Brussaard A.B., Wossink J., Lodder J.C., Kits K.S. Progesterone- metabolite prevents protein kinase C-dependent modulation of γ-aminobutyric acid type A receptors in oxytocin neurons. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3625-3630.
17. A receptor by progesterone metabolites. Proc. R. Soc. Lond. B: Biol. Sci. 231:1987;359-369.
18. A receptor. J. Pharmacol. Exp. Ther. 280:1997;1284-1295.
19. Colombini M., Blachly-Dyson E., Forte M. VDAC, a channel in the outer mitochondrial membrane. Ion Channels. 4:1996;169-202.
20. A IPSCs during development in rat hippocampal or cerebellar slices. J. Physiol. (Lond.). 521:1999;437-449.
21. A receptor activity by alphaxalone. Br. J. Pharmacol. 90:1987;491-500.
22. A receptors. Brain Res. Brain Res. Rev. 37:2001;91-97.
23. Darbandi-Tonkabon R., Hastings W.R., Zeng C.M., Akk G., Manion B.D., Bracamontes J.R., Steinbach J.H., Mennerick S.J., Covey D.F., Evers A.S. Photoaffinity labeling with a neuroactive steroid analogue. 6-azi-pregnanolone labels voltage-dependent anion channel-1 in rat brain. J. Biol. Chem. 278:2003;13196-13206.
24. A receptor subunit. Nature. 385:1997;820-823.
25. Fancsik A., Linn D.M., Tasker J.G. Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J. Neurosci. 20:2000;3067-3075.
26. A receptor subunit proteins and messenger RNAs within hypothalamic magnocellular neurons. Neuroscience. 64:1995;1129-1143.
27. A receptor plasticity during long-term exposure to and withdrawal from progesterone. Brain Res. Brain Res. Rev. 37:2001;81-90.
28. Fritschy J.M., Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol. Ther. 98:2003;299-323.
29. A-receptor subtypes during postnatal development: an immunohistochemical study. J. Neurosci. 14:1994;5302-5324.
30. Gasior M., Carter R.B., Witkin J.M. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol. Sci. 20:1999;107-112.
31. Haage D., Johansson S. Neurosteroid modulation of synaptic and GABA-evoked currents in neurons from the rat medial preoptic nucleus. J. Neurophysiol. 82:1999;143-151.
32. Hadingham K.L., Wingrove P.B., Wafford K.A., Bain C., Kemp J.A., Palmer K.J., Wilson A.W., Wilcox A.S., Sikela J.M., Ragan C.I. Role of the β subunit in determining the pharmacology of human γ-aminobutyric acid type A receptors. Mol. Pharmacol. 44:1993;1211-1218.
33. Hamann M., Rossi D.J., Attwell D. Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron. 33:2002;625-633.
34. A receptor. Curr. Top. Med. Chem. 2:2002;887-902.
35. A receptors in rat CA1 and dentate gyrus neurons. Neuropharmacology. 45:2003;873-883.
36. Harrison N.L., Simmonds M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323:1984;287-292.
37. Harrison N.L., Vicini S., Barker J.L. A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J. Neurosci. 7:1987;604-609.
38. A receptor modulators and alcohol in mice lacking PKCε Nat. Neurosci. 2:1999;997-1002.
39. Hodge C.W., Raber J., McMahon T., Walter H., Sanchez-Perez A.M., Olive M.F., Mehmert K., Morrow A.L., Messing R.O. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cε J. Clin. Invest. 110:2002;1003-1010.
40. Hollrigel G.S., Soltesz I. Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. J. Neurosci. 17:1997;5119-5128.
41. A receptor-mediated currents in the rat forebrain. J. Neurophysiol. 83:2000;3299-3309.
42. 3 subunit. FASEB J. 17:2003;250-252.
43. A receptor pharmacological properties. Mol. Pharmacol. 55:1999;444-452.
44. Kneussel M., Betz H. Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model. Trends Neurosci. 23:2000;429-435.
45. A receptors in supraoptic nucleus around parturition. J. Neurosci. 23:2003;788-797.
46. A receptor. Trends Pharmacol. Sci. 8:1987;224-227.
47. A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
48. A receptors by endogenous and synthetic neuroactive steroids. Brain Res. Brain Res. Rev. 37:2001;68-80.
49. A receptors. Brain Res. Mol. Brain Res. 52:1997;173-181.
50. A/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology. 34:1995;245-254.
51. A receptor function by neuroactive steroids. Brain Res. 819:1999;75-82.
52. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
53. A receptor-ionophores. Neuropharmacology. 44:2003;994-1002.
54. Matsumoto K., Uzunova V., Pinna G., Taki K., Uzunov D.P., Watanabe H., Mienville J.M., Guidotti A., Costa E. Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology. 38:1999;955-963.
55. McEwen B.S., Coirini H., Schumacher M. Steroid effects on neuronal activity: when is the genome involved? Ciba Found. Symp. 153:1990;3-12.
56. Melcangi, R.C., Magnaghi, V., Galbiati, M., Martini, L., 2001. Formation and effects of neuroactive steroids in the central and peripheral nervous system. In: Biggio, G., Purdy, R.H. (Eds.), Neurosteroids and Brain Function; Int. Rev. Neurobiol. 46, 146-176.
57. Mellon S.H., Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46:2001;33-78.
58. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., Lagenaur C., Tretter V., Sieghart W., Anagnostaras S.G., Sage J.R., Fanselow M.S., Guidotti A., Spigelman I., Li Z., DeLorey T.M., Olsen R.W., Homanics G.E. Attenuated sensitivity to neuroactive steroids in γ-aminobutyrate type A receptor δ subunit knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12905-12910.
59. Mitchell S.J., Silver R.A. Shunting inhibition modulates neuronal gain during synaptic excitation. Neuron. 38:2003;433-445.
60. Mody I., De Koninck Y., Otis T.S., Soltesz I. Bridging the cleft at GABA synapses in the brain. Trends Neurosci. 17:1994;517-525.
61. Mohler H., Fritschy J.M., Rudolph U. A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300:2002;2-8.
62. Morrow A.L., VanDoren M.J., Penland S.N., Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res. Brain Res. Rev. 37:2001;98-109.
63. Moss S.J., Smart T.G. Constructing inhibitory synapses. Nat. Rev. Neurosci. 2:2001;240-250.
64. A receptors during postnatal development. Neuroscience. 118:2003;655-666.
65. Nusser Z., Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J. Neurophysiol. 87:2002;2624-2628.
66. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
67. A receptor agonist muscimol. Neuropharmacology. 39:2000;440-448.
68. A receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo- hypophyseal coculture model. J. Physiol. (Lond.). 500:1997;475-485.
69. Porcello D.M., Huntsman M.M., Mihalek R.M., Homanics G.E., Huguenard J.R. Intact synaptic GABAergic inhibition and altered neurosteroid modulation of thalamic relay neurons in mice lacking δ subunit. J. Neurophysiol. 89:2003;1378-1386.
70. A receptor function. Neuropharmacology. 44:2003;49-55.
71. Purdy R.H., Morrow A.L., Moore P.H. Jr., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4553-4557.
72. Reddy D.S. Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol. Sci. 24:2003;103-106.
73. Reith C.A., Sillar K.T. Pre- and postsynaptic modulation of spinal GABAergic neurotransmission by the neurosteroid, 5β-pregnan-3α-ol-20- one. Brain Res. 770:1997;202-212.
74. A receptor isoforms. J. Neurosci. 23:2003;8608-8617.
75. Robel, P., Scumacher, M., Baulieu, E.E., 1999. Neurosteroids: from definition and biochemistry to physiopathological function. Neurosteroids: A New Regulatory Function in the Nervous System. Humana Press, Totowa, NJ, pp. 1-26.
76. A receptors and glomerular geometry. Neuron. 20:1998;783-795.
77. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology. 28:2003;139-168.
78. Sanna E., Murgia A., Casula A., Biggio G. Differential subunit dependence of the actions of the general anesthetics alphaxalone and etomidate at γ-aminobutyric acid type A receptors expressed in Xenopus laevis oocytes. Mol. Pharmacol. 51:1997;484-490.
79. Schlichter R., Rybalchenko V., Poisbeau P., Verleye M., Gillardin J. Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology. 39:2000;1523-1535.
80. Schofield C.N. Potentiation of inhibition by general anesthetics in neurons of the olfactory cortex in vitro. Pfluger's Arch. 38:1980;249-255.
81. Selye H. Anesthetic effects of steroid hormones. Proc. Soc. Exp. Biol. Med. 46:1941;116-121.
82. Selye H. The antagonism between anesthetic steroid hormones and pentamethylentetrazol (metrazol). J. Lab. Clin. Med. 27:1942;1051-1053.
83. Semyanov A., Walker M.C., Kullmann D.M. GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat. Neurosci. 6:2003;484-490.
84. A receptor subtypes. Curr. Top. Med. Chem. 2:2002;795-816.
85. A receptors. Trends Pharmacol. Sci. 18:1997;425-429.
86. A receptors: protein phosphorylation. In: Mohler, H. (Ed.), Pharmacology of GABA and Glycine transmission. Handbook of Experimental Pharmacology, vol. 150. Springer, Berlin, pp. 195-226.
87. A receptors. Trends Pharmacol. Sci. 16:1995;162-168.
88. 4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 392:1998a;926-930.
89. 4 subunit in association with increased anxiety. J. Neurosci. 18:1998b;5275-5284.
90. A conductances in hippocampal neurons. J. Neurosci. 22:2002;RC223.
91. A receptors. Soc. Neurosci. Abs. 28:2002;148.7.
92. A receptor in rat thalamus. Mol. Pharmacol. 56:1999;110-115.
93. A receptor ε subunit results in insensitivity to anaesthetics. Neuropharmacology. 43:2002;662-668.
94. A receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J. Physiol. (Lond.). 456:1992;215-245.
95. A receptor δ subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology. 43:2002;646-650.
96. A receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur. J. Neurosci. 9:1997;533-548.
97. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wang Y., Liu F., Wang Y.T. Control of synaptic strength, a novel function of Akt. Neuron. 38:2003a;915-928.
98. 2 subunits produces long-term depression at CA1 inhibitory synapses. J. Neurosci. 23:2003b;826-836.
99. A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov. Today. 8:2003;445-450.
100. A receptor subunit conferring atypical functional properties. J. Neurosci. 17:1997;5027-5037.
101. Williams S.R., Buhl E.H., Mody I. The dynamics of synchronized neurotransmitter release determined from compound spontaneous IPSCs in rat dentate granule neurons in vitro. J. Physiol. (Lond.). 510:1998;477-497.
102. 3 subunit. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4569-4573.
103. A receptor diversity. Neuropharmacology. 35:1996;1139-1160.
104. A receptors containing the δ subunit. J. Neurosci. 22:2002;1541-1549.
105. A receptors. Neuropharmacology. 43:2002;619-633.
106. A receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol. Pharmacol. 63:2003;2-8.
107. A channel deactivation by altering kinetics of desensitized states. J. Neurosci. 17:1997;4022-4031.
108. A receptors. J. Neurosci. 16:1996;6648-6656.